Cargando…
Limbic encephalitis: Clinical spectrum and long-term outcome from a developing country perspective
INTRODUCTION: Limbic encephalitis (LE) is characterized by rapidly progressive short-term memory loss, psychiatric symptoms and seizures. We describe the clinical spectrum, underlying etiology and long-term follow-up of patients with LE from India. MATERIALS AND METHODS: This prospective study inclu...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090840/ https://www.ncbi.nlm.nih.gov/pubmed/25024565 http://dx.doi.org/10.4103/0972-2327.132615 |
_version_ | 1782480702254612480 |
---|---|
author | Jagtap, Sujit Abajirao Das, Gopal Krishna Kambale, Harsha J. Radhakrishnan, Ashalatha Nair, M.D. |
author_facet | Jagtap, Sujit Abajirao Das, Gopal Krishna Kambale, Harsha J. Radhakrishnan, Ashalatha Nair, M.D. |
author_sort | Jagtap, Sujit Abajirao |
collection | PubMed |
description | INTRODUCTION: Limbic encephalitis (LE) is characterized by rapidly progressive short-term memory loss, psychiatric symptoms and seizures. We describe the clinical spectrum, underlying etiology and long-term follow-up of patients with LE from India. MATERIALS AND METHODS: This prospective study included patients during the period of January 2009 and December 2011 with the clinical features consistent with LE with one or more of the following: (1) Magnetic resonance imaging (MRI) evidence of temporal lobe involvement; (2) cerebrospinal fluid inflammatory abnormalities, or (3) detection of antineuronal antibodies. Patients with metastasis, infection, metabolic and nutritional deficits, stroke, were excluded. RESULTS: There were 16 patients (9 females), mean age of presentation was 36.6 years (range 15-69 years). The mean duration of symptoms before presentation was 11 months (range 5 days-2 years). The most common symptom at presentation was short-term memory impairment in 7 patients followed by seizures in 5 and behavioral changes in three. Nine patients had seizures, 11 had change in behavior, language involvement in eight, cerebellar features in 3 and autonomic dysfunction in two. Four patients had associated malignancy, 3 of four presented with neurological symptoms and on investigations found to be have malignancy. Antineuronal antibody testing was done in 6 of 12 non paraneoplastic and two paraneoplastic patients, one positive for N-methyl-D-aspartate and one for anti-Hu antibody. MRI brain showed typical fluid attenuated inversion recovery or T2 bilateral temporal lobe hyperintensities in 50% of patients. At a mean follow-up of 21 months (3-36 months), 10 patients improved, 4 patients remained same and two patients expired. CONCLUSION: Early recognition of LE is important based upon clinical, MRI data in the absence of antineuronal surface antibody screen in developing nations. Early institution of immunotherapy will help in improvement in outcome of these patients in long-term. |
format | Online Article Text |
id | pubmed-4090840 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-40908402014-07-14 Limbic encephalitis: Clinical spectrum and long-term outcome from a developing country perspective Jagtap, Sujit Abajirao Das, Gopal Krishna Kambale, Harsha J. Radhakrishnan, Ashalatha Nair, M.D. Ann Indian Acad Neurol Original Article INTRODUCTION: Limbic encephalitis (LE) is characterized by rapidly progressive short-term memory loss, psychiatric symptoms and seizures. We describe the clinical spectrum, underlying etiology and long-term follow-up of patients with LE from India. MATERIALS AND METHODS: This prospective study included patients during the period of January 2009 and December 2011 with the clinical features consistent with LE with one or more of the following: (1) Magnetic resonance imaging (MRI) evidence of temporal lobe involvement; (2) cerebrospinal fluid inflammatory abnormalities, or (3) detection of antineuronal antibodies. Patients with metastasis, infection, metabolic and nutritional deficits, stroke, were excluded. RESULTS: There were 16 patients (9 females), mean age of presentation was 36.6 years (range 15-69 years). The mean duration of symptoms before presentation was 11 months (range 5 days-2 years). The most common symptom at presentation was short-term memory impairment in 7 patients followed by seizures in 5 and behavioral changes in three. Nine patients had seizures, 11 had change in behavior, language involvement in eight, cerebellar features in 3 and autonomic dysfunction in two. Four patients had associated malignancy, 3 of four presented with neurological symptoms and on investigations found to be have malignancy. Antineuronal antibody testing was done in 6 of 12 non paraneoplastic and two paraneoplastic patients, one positive for N-methyl-D-aspartate and one for anti-Hu antibody. MRI brain showed typical fluid attenuated inversion recovery or T2 bilateral temporal lobe hyperintensities in 50% of patients. At a mean follow-up of 21 months (3-36 months), 10 patients improved, 4 patients remained same and two patients expired. CONCLUSION: Early recognition of LE is important based upon clinical, MRI data in the absence of antineuronal surface antibody screen in developing nations. Early institution of immunotherapy will help in improvement in outcome of these patients in long-term. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4090840/ /pubmed/25024565 http://dx.doi.org/10.4103/0972-2327.132615 Text en Copyright: © Annals of Indian Academy of Neurology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Jagtap, Sujit Abajirao Das, Gopal Krishna Kambale, Harsha J. Radhakrishnan, Ashalatha Nair, M.D. Limbic encephalitis: Clinical spectrum and long-term outcome from a developing country perspective |
title | Limbic encephalitis: Clinical spectrum and long-term outcome from a developing country perspective |
title_full | Limbic encephalitis: Clinical spectrum and long-term outcome from a developing country perspective |
title_fullStr | Limbic encephalitis: Clinical spectrum and long-term outcome from a developing country perspective |
title_full_unstemmed | Limbic encephalitis: Clinical spectrum and long-term outcome from a developing country perspective |
title_short | Limbic encephalitis: Clinical spectrum and long-term outcome from a developing country perspective |
title_sort | limbic encephalitis: clinical spectrum and long-term outcome from a developing country perspective |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090840/ https://www.ncbi.nlm.nih.gov/pubmed/25024565 http://dx.doi.org/10.4103/0972-2327.132615 |
work_keys_str_mv | AT jagtapsujitabajirao limbicencephalitisclinicalspectrumandlongtermoutcomefromadevelopingcountryperspective AT dasgopalkrishna limbicencephalitisclinicalspectrumandlongtermoutcomefromadevelopingcountryperspective AT kambaleharshaj limbicencephalitisclinicalspectrumandlongtermoutcomefromadevelopingcountryperspective AT radhakrishnanashalatha limbicencephalitisclinicalspectrumandlongtermoutcomefromadevelopingcountryperspective AT nairmd limbicencephalitisclinicalspectrumandlongtermoutcomefromadevelopingcountryperspective |